Systemic JIA: new developments in the understanding of the pathophysiology and therapy.
about
IL-1 Inhibition in Systemic Juvenile Idiopathic ArthritisExonic deletion of CASP10 in a patient presenting with systemic juvenile idiopathic arthritis, but not with autoimmune lymphoproliferative syndrome type IIa.Soluble CD25 in serum: a potential marker for subclinical macrophage activation syndrome in patients with active systemic onset juvenile idiopathic arthritis.Cytokine-dependent but acquired immunity-independent arthritis caused by DNA escaped from degradation.Emerging role of antioxidants in the protection of uveitis complications.How I treat hemophagocytic lymphohistiocytosis.Systemic arthritis in children: a review of clinical presentation and treatmentStudy of the association between CD28/CTLA-4 expression and disease activity in juvenile idiopathic arthritis.Recent advances in the diagnosis and treatment of hemophagocytic lymphohistiocytosis.Plasma profiles in active systemic juvenile idiopathic arthritis: Biomarkers and biological implications.Sufficient production of geranylgeraniol is required to maintain endotoxin tolerance in macrophages.Follistatin-like protein 1 and the ferritin/erythrocyte sedimentation rate ratio are potential biomarkers for dysregulated gene expression and macrophage activation syndrome in systemic juvenile idiopathic arthritis.A comparison of three treatment strategies in recent onset non-systemic Juvenile Idiopathic Arthritis: initial 3-months results of the BeSt for Kids-study.Tocilizumab: molecular intervention therapy in children with systemic juvenile idiopathic arthritis.HDAC inhibition in rheumatoid arthritis and juvenile idiopathic arthritis.Glucocorticoids in the management of systemic juvenile idiopathic arthritis.Pathogenesis of systemic inflammatory diseases in childhood: "Lessons from clinical trials of anti-cytokine monoclonal antibodies for Kawasaki disease, systemic onset juvenile idiopathic arthritis, and cryopyrin-associated periodic fever syndrome".Methotrexate in juvenile idiopathic arthritis: towards tailor-made treatment.DNA degradation and its defects.Therapeutic Potential of Interferon-γ and Its Antagonists in Autoinflammation: Lessons from Murine Models of Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome.IL-6 blockers in systemic onset juvenile idiopathic arthritis.Fine-mapping the MHC locus in juvenile idiopathic arthritis (JIA) reveals genetic heterogeneity corresponding to distinct adult inflammatory arthritic diseasesJuvenile idiopathic arthritis: management and therapeutic options.Effects of HLA-DRB1 alleles on susceptibility and clinical manifestations in Japanese patients with adult onset Still's disease.Comparison of biomarkers for systemic juvenile idiopathic arthritis.Real-life 10-year retention rate of first-line anti-TNF drugs for inflammatory arthritides in adult- and juvenile-onset populations: similarities and differences.Trends in prescription of biological agents and outcomes of juvenile idiopathic arthritis: results of the Dutch national Arthritis and Biologics in Children Register.Atopy in children with systemic onset juvenile idiopathic arthritis (SoJIA) is associated with a worse outcome.Effectiveness of first-line treatment with recombinant interleukin-1 receptor antagonist in steroid-naive patients with new-onset systemic juvenile idiopathic arthritis: results of a prospective cohort study.Predicting unfavorable long-term outcome in juvenile idiopathic arthritis: results from the Nordic cohort study.Laboratory parameters identify familial haemophagocytic lymphohistiocytosis from other forms of paediatric haemophagocytosisIL-6, IL-17 and Stat3 are required for auto-inflammatory syndrome development in mouse
P2860
Q28078134-116CB64E-3428-438E-913E-F3426E9FEE58Q33394404-C27AA608-6FF2-4927-B4FB-9743F9F19841Q33412621-E7DD8640-B075-40C9-BF6A-72A44668FB8DQ34320329-5EBEB790-E847-4437-956B-FDBC8C2D7CEFQ34887046-36B162E9-B09D-4171-BA20-6EED67E05E7FQ35483540-DC14AC15-AA5C-4767-8F77-EAF12403E628Q35659928-B0EE4C5D-DF25-433E-89A4-536BAD429F71Q35753979-02B5D8F3-DDB9-4D84-8054-0BA3D651E9A4Q36245985-74F5EB0D-69D1-4BD5-B10A-86D684C6BCD5Q36453159-F901CF59-B905-4583-A6DD-042D300F8709Q37305397-8C719CF2-1D05-4DA8-97EA-47331003CCA9Q37451624-4B75E055-9E6A-43D9-B53B-AF0ADB8B7B2DQ37627929-E1283A7F-013C-474D-9134-E586311C39BFQ37786628-6ECBF496-E3EF-401D-9193-C40CE2397FD5Q37838731-F730C9B1-7E0F-45E4-BE71-10942DC229D2Q38118210-DC70709D-5ABC-467A-9874-5F842A1E8EE2Q38212949-3B3F23E1-AAFE-4862-9F34-7D3F89CE0B75Q38214382-E46F176F-3F5A-4D4E-B590-C91F46253118Q38217081-88172F56-7F47-47DA-AB77-FEE279278D59Q38648790-DF6E705C-B13C-4A1C-B5D4-C2A91A64503AQ38661146-57237EBB-1C67-4CEF-806A-6FF6A8F90EE9Q39080731-CCEDC1C2-D1A6-4D54-AC44-3C4C90C67E00Q39243858-0A922A43-5C6B-49C9-B863-AF6B05FA7423Q40045121-0A5D6129-D75F-4BA0-BD39-02D8CEAF176FQ40143547-A979ADBA-95DD-416D-B082-9B9BB5F38C3BQ40179378-EF361A2A-83C5-44A7-B3FA-51231CFC8657Q43689633-9C80D5CE-4BF4-4B26-AF66-7FE50A5CCC54Q51155090-4D27CA36-1A7D-4329-BD00-41FCD45910EBQ51740150-21330E7F-7B80-47FB-A739-8E9BE8861CE5Q55023560-D82AE912-2284-4A74-A6C3-72A90C9A7B22Q58412663-3C0C6C64-73C0-4202-A533-BA19678B6F53Q58562869-DD8F4272-2DEE-4521-8387-A04F6E64B481
P2860
Systemic JIA: new developments in the understanding of the pathophysiology and therapy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Systemic JIA: new developments in the understanding of the pathophysiology and therapy.
@en
Systemic JIA: new developments in the understanding of the pathophysiology and therapy.
@nl
type
label
Systemic JIA: new developments in the understanding of the pathophysiology and therapy.
@en
Systemic JIA: new developments in the understanding of the pathophysiology and therapy.
@nl
prefLabel
Systemic JIA: new developments in the understanding of the pathophysiology and therapy.
@en
Systemic JIA: new developments in the understanding of the pathophysiology and therapy.
@nl
P2093
P2860
P1476
Systemic JIA: new developments in the understanding of the pathophysiology and therapy.
@en
P2093
Alexei A Grom
Sebastiaan J Vastert
Wietse Kuis
P2860
P304
P356
10.1016/J.BERH.2009.08.003
P577
2009-10-01T00:00:00Z